Guru Ownership Trend
Guru Analysis for Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc. (DNLI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $53.56 M.
Top institutional holders include Ken Fisher and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $7.82 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 278.7%. Conversely, Ken Fisher reduced exposure by 0.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Denali Therapeutics Inc. (DNLI)
Major holders include Ken Fisher ($62.09 M), Cliff Asness ($9.99 M), Paul Tudor Jones ($1.05 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.88 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.82 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited DNLI. The total reported sell value was $584,692.74.
Yes, 1 managers opened new positions in DNLI, and 1 increased their existing holdings. The total reported buy value was $8.41 M.